Predicting Mortality in Systemic Sclerosis

This publication has 36 references indexed in Scilit:

• Prediction of five-year survival following presentation with scleroderma: Development of a simple model using three disease factors at first visit
  Arthritis & Rheumatism, 1999
• Is Anti-Topoisomerase I a Serum Marker of Pulmonary Involvement in Systemic Sclerosis?
  Chest, 1999
• Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy
  Nature Genetics, 1998
• Increased prevalence of systemic sclerosis in a native american tribe in oklahoma. Association with an amerindian HLA haplotype
  Arthritis & Rheumatism, 1996
• SURVIVAL FOLLOWING THE ONSET OF SCLERODERMA: RESULTS FROM A RETROSPECTIVE INCEPTION COHORT STUDY OF THE UK PATIENT POPULATION
  Rheumatology, 1995
• Comparative studies of the major histocompatibility complex in french canadian and non–french canadian caucasians with systemic lupus erythematosus
  Arthritis & Rheumatism, 1993
• Predictors of survival in systemic sclerosis (Scleroderma)
  Arthritis & Rheumatism, 1991
• Pronostic de la sclérodermie généralisée
  La Revue de Médecine Interne, 1986
• The Will Rogers Phenomenon
  New England Journal of Medicine, 1985
• Serological markers in progressive systemic sclerosis: clinical correlations.
  Annals of the Rheumatic Diseases, 1983